---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-25-276249"
form_type: "8-K"
ticker: "LCTX"
cik: "0000876343"
company_name: "Lineage Cell Therapeutics, Inc."
filed_at: "2025-11-12T23:59:59+00:00"
generated_at: "2026-05-16T22:01:28.558117+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Lineage Cell Therapeutics sells 12M shares at $1.75 to Janus Henderson, grossing $21M

## Summary
- Sold 12,000,000 common shares at $1.75 per share to Janus Henderson Investors in a block transaction.
- Gross proceeds of $21 million before fees and expenses; net proceeds not disclosed.
- Transaction executed under the company's existing at-the-market offering program.
- Shares trade on NYSE American under ticker LCTX.

## SEC filing metadata
- accession: 0001193125-25-276249
- form_type: 8-K
- ticker: LCTX
- cik: 0000876343
- company_name: Lineage Cell Therapeutics, Inc.
- filed_at: 2025-11-12T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/876343/000119312525276249/0001193125-25-276249-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/876343/000119312525276249/lctx-20251112.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-25-276249
- JSON: https://secwatch.observer/filing/0001193125-25-276249.json
- Plain text: https://secwatch.observer/filing/0001193125-25-276249.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.